Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient-controlled versus nurse-controlled propofol + remifentanil sedation during ventricular tachycardia ablation
2016-004455-78Phase 4Active
- Sponsor
- Region Östergötland
- Start
- Apr 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propofol and remifentanil in ventricular tachycardia (VT) (2 arms), sponsored by Region Östergötland. Primary endpoint: Treatability. Started Apr 2017; status: active.
02
Drugs
propofolremifentanil
03
Conditions
ventricular tachycardia (VT)
Beyond the preview
Go deeper on 2016-004455-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004455-78.